Friday 6 November 2026 Export MRK’s income statement to Excel — free account

Merck & Co., Inc.

MRK Healthcare Drug Manufacturers General

Merck & Co., Inc.’s revenue for fiscal 2025 (year ended December 2025) was $65.0 billion, up 1.31% from fiscal 2024.

Revenue: +4.68%
EPS: −130.7%
Free cash flow: +77.0%
Total debt: +50.4%

Quarter to September 2026, against a year earlier

146.92 3.44 −2.29%

Follow MRK

Alert me

Market cap: $362.5B
P/E: 118×
Fwd P/E: 109×
Dividend yield: 2.31%
F-score: 4/9
Altman Z: 3.77
Beneish M: −2.27
Dividend safety: 74/100

Overview Business Profile Earnings & Analysis Segments Valuation Filings

Merck & Co., Inc. (MRK) P/S ratio

Alert me on P/S ratio

As of 5 November 2026, Merck & Co., Inc. (MRK) trades at a P/S ratio of 5.4×. Over the past ten years it has ranged from 2.9× (May 2025) to 5.8× (January 2020); the current reading is higher than 96% of that period. That is above the Drug Manufacturers General industry median of 3.5× and above the Healthcare sector median of 3.5×.

Embed this chart

Code for your page

<iframe src="https://stockrow.com/embed/MRK/ps-ratio" width="100%" height="360" style="border:0" loading="lazy" title="Merck &amp; Co., Inc. P/S ratio, 10 years"></iframe>
<p style="font-size:12px">Source: <a href="https://stockrow.com/MRK/metrics/ps-ratio">Merck &amp; Co., Inc. (MRK) P/S ratio — stockrow.com</a></p>

Period	P/S ratio	Change
FY2025	4.1×	3.20%
FY2024	3.9×	(17.86%)
FY2023	4.8×	0.68%
FY2022	4.7×	19.23%
FY2021	4.0×	(17.24%)
FY2020	4.8×	(16.41%)
FY2019	5.8×	23.90%
FY2018	4.6×	25.80%
FY2017	3.7×	(8.47%)
FY2016	4.0×	12.25%

Period	P/S ratio	Change
Sep 2026	5.3×	11.72%
Jun 2026	4.8×	5.45%
Mar 2026	4.5×	11.61%
Dec 2025	4.1×	24.26%
43 more quarters	Free account

Against its own ten years

Low 2.9× High 5.8×

Ten-year median 4.3×

Current reading's percentile 95

Company	P/S ratio
PFE Pfizer Inc. compare	2.7×
NVO Novo Nordisk A/S compare	3.5×
AZN AstraZeneca PLC compare	4.7×
NVS Novartis AG compare	5.4×
MRK Merck & Co., Inc.	5.4×
AMGN Amgen Inc. compare	6.4×
JNJ Johnson & Johnson compare	6.6×
GILD Gilead Sciences, Inc. compare	6.7×
ABBV AbbVie Inc. compare	7.7×
Drug Manufacturers General industry median	3.5×
Healthcare sector median	3.5×
Market median	1.9×

What P/S ratio is

Price to Sales Ratio shows how much investors pay for each dollar of a company’s annual sales, whether or not it is profitable.

(Stock Price × Shares (Basic, Weighted) (latest quarter)) ÷ Revenue (TTM)

The full definition of P/S ratio →

Merck & Co., Inc. (MRK) P/S ratio

P/S ratio, daily

Annual newest first

Quarterly newest first

Against its own ten years

P/S ratio against peers

What P/S ratio is

More on MRK

P/S ratio, daily

Annual newest first

Quarterly newest first

Against its own ten years

P/S ratio against peers

What P/S ratio is

More on MRK

Stockrow Weekly